Description
Early detection of immunogenicity reactions is a key component of a drug development programme.
This 2-day course shows you how to detect, reduce and characterise unwanted immunogenicity, interpret the last regulatory guidelines and formulate a winning strategy that you can implement into your business immediately.
Most of the sessions comprise a formal presentation followed by facilitated break-out groups where delegates will be given the opportunity to apply some of the principles from the taught sections. The break-out sessions will be fully supported with background documentation and experts will be available to facilitate and guide the groups during these sessions
